The New Gold Trade Dominating on Wall Street
Wall Street has been making headlines lately for piling into gold. According to Dr. David Eifrig, the gold bull run is just getting started. He says you should move your money to his No. 1 gold stock immediately (not a miner or ETF but it has 1,000% upside potential.)
Financials
| Curr Year EPS Estimate | 22.87 |
| Next Quarter EPS Estimate | 6.11 |
| Profit Margin | 32.76% |
| Operating Margin | 42.41 |
| Return on Assets | 0.20 |
| Return on Equity | 0.71 |
| Revenue | 46.7B |
| Earnings Per Share | 3.62 |
| Revenue Per Share | 71.00 |
| Gross Profit | 259,900,997,632 |
| Quarterly Revenue Growth | 0.05 |
General
| Name | Novo Nordisk ADR |
| Ticker | NVO |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 78,554 |
About Novo Nordisk ADR
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with UNICEF to tackle childhood obesity; and with Valo Health, Inc. to discover and develop novel drug programmes for cardiometabolic space. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Dividend
Novo Nordisk ADR pays out a dividend of $1.77 per share, with a dividend yield of 3.60%.
NVO's last dividend payment was made to shareholders on August 26, 2025.
They pay out 35.93% of their earnings out as a dividend.
Recent Dividends
| Sep 29, 2025 | $0.00 |
| Aug 26, 2025 | $0.58 |
| Apr 8, 2025 | $1.10 |
| Aug 26, 2024 | $0.51 |
| Apr 2, 2024 | $0.93 |
Trump administration says it has trade frameworks with Argentina, Ecuador, El Salvador and Guatemala
WASHINGTON (AP) — The Trump administration said Thursday that it had reached trade frameworks with Argentina, Ecuador, El Salvador and Guatemala.
Zohran Mamdani Says No More Thanking Veterans Today, Forgetting Tomorrow — Trump, Obama And Others Express Gratitude For Service
America's top political and tech leaders — including Donald Trump, Barack Obama, Tim Cook, and Sundar Pichai — marked Veterans Day 2025 with tributes honoring the courage and sacrifice of U.S. service members.
Buy This Stock Tomorrow? - Ad
A renowned former hedge fund manager - friends to some of the biggest investors in the world - just released a new list of his favorite AI stocks... and not a single Magnificent 7 name made the cut. Instead, an AI stock you've likely never heard of just flagged as "near-perfect" in his new investing scoring system.
Marjorie Taylor Greene Buys 6 Stocks: Buffett, Health Care — And This Magnificent 7 Stock
Marjorie Taylor Greene discloses buying more stocks in October. Here's a look at what she added to her portfolio.
These are the 37 donors helping pay for Trump's $300 million White House ballroom
WASHINGTON (AP) — President Donald Trump says his $300 million White House ballroom will be paid for “100% by me and some friends of mine.”
This Overlooked Memecoin Is Showing Early Breakout Signals - Ad
We've been tracking one small memecoin that checks all the boxes: strong on-chain signals, real traction, and an entry point that could offer serious upside. It's not on many radars yet-but that could change fast.
How To Earn $500 A Month From Applied Materials Stock Ahead Of Q4 Earnings
Applied Materials, Inc. is expected to report lower quarterly earnings and revenue on Nov. 13. Analysts recommend buying with a $250 target.
Why a Visa-Mastercard legal settlement could lead to your rewards credit card getting declined
NEW YORK (AP) — Visa and Mastercard have proposed a settlement in their long-running legal dispute with merchants and retailers over how much they charge merchants to accept their cards.
The K7 Is Changing the Economics of Security - Ad
$65-an-hour guards can't compete with a $15-an-hour AI machine that never sleeps. The K7 delivers nonstop protection and smarter analytics that improve with every patrol.
Congress Ended The Shutdown — But At The Cost Of Re-Criminalizing These THC Products In A Last-Minute Deal That Could Reshape The Cannabis Industry
Congress appears set to end the record-long government shutdown, but a controversial provision tucked into the spending bill is sparking alarm across the hemp and cannabis industry.
Jim Cramer: Chipotle Is 'Too Expensive,' Buy This Plane Maker
On "Mad Money," Cramer discusses Henry Schein, Bloom Energy, Tyler Technologies, Boeing and Chipotle Mexican Grill.
America's Next Security Revolution Has Begun - Ad
Built for endurance, powered by AI, and proven in the field, the K7 is redefining protection for ports, energy hubs, and cities across the nation. The rollout is already underway.
Huntington Bancshares buying Cadence Bank in $7.4 billion all-stock deal
Huntington Bancshares is buying regional bank Cadence Bank in an all-stock deal valued at $7.4 billion that will strengthen its position across the Southern U.S.
Top economists call on world leaders to set up an international panel on inequality
CAPE TOWN, South Africa (AP) — Hundreds of top economists and other experts, including former U.S. Treasury Secretary Janet Yellen, called on Friday for the world to set up an independent international panel on .
After 50 Years of Chemo, One Biotech Could Lead the Next Cancer Breakthrough - Ad
For decades, toxic chemotherapy defined cancer care. This biotech's innovative approach could finally change that. With early results showing precision without poison, this story is one investors will want to see early.
The Real Reason This Analyst Still Calls Nebius His Favorite Neocloud Player
Nebius Group (NASDAQ: NBIS) reported strong Q3 results, boosting capacity & revenue guidance through 2026. Analyst reiterated Buy rating.
Time To Sell XRP? These 3 Indicators Scream 'Take Profits'
XRP (CRYPTO: XRP) fell below key moving averages on Wednesday, signaling fading bullish momentum as multiple indicators flashed a strong sell warning.
"Tech Prophet" Who Predicted the iPhone Now Predicts... - Ad
George Gilder - who predicted the iPhone 17 years early and gave Reagan the first microchip - is making his boldest call yet. He says an American nanotech "super-convergence" could mint more millionaires than any event in recent memory. He's found 3 stocks set to benefit before November 18's bombshell.
Opendoor Stock Gains Ground: What's Behind The Recent Momentum?
Opendoor Technologies Inc (NASDAQ:OPEN) shares are trading higher on Wednesday. Here's what you need to know.
Meta Stock Continues To Slide: What's Going On?
Meta Platforms Inc (NASDAQ:META) shares are trading lower on Wednesday. Here's everything you need to know.
Speculative? Yes. But This Memecoin Has Serious Fundamentals. - Ad
Most memecoins are driven by hype-but this one might be different. Backed by a real use case and unexpected investor interest, our analysts believe it could emerge as one of the strongest performers in the coming cycle.
FDA says drugmakers have recalled a blood pressure medicine tainted with a cancer-causing chemical
The U.S. Food and Drug Administration says drugmakers have recalled more than a half-million bottles of the blood pressure medication prazosin hydrochloride over concerns it may include a cancer-causing chemical.
Palantir, Kimberly-Clark, Hims & Hers, Navitas And Cipher Mining: Why These 5 Stocks Are On Investors' Radars Today
PLTR, KMB, HIMS, NVTS, CIFR were among the stocks seen trending among investors on Monday, Nov. 3, 2025.
Another Gold High? Here's the Move Wall Street Is Missing ... - Ad
Gold just surged past $4,200, up 45% in a year - but Sean Brodrick says $6,900 could be next. History shows when gold booms, one hidden play has delivered far bigger gains - 21x, 49x, even 1,386x. The same strategy once handed 26,000% profits. And Sean says it's back on the table now.
Court Blocks Trump's SNAP Reductions, But Stricter Eligibility Rules Begin
New work requirements for SNAP begin Saturday, but benefits may not be issued through November due to the government shutdown.
Why Did Salarius (SLRX) Shares Soar Over 23% After-Hours?
Salarius Pharmaceuticals shares jumped 23.7% in after-hours trading Tuesday, closing at $1.21 following its public offering announcement.
Why Wall Street Is Piling Into the "Debasement Trade" - Ad
Wall Street has been making headlines lately for piling into a strange new money move. What they've dubbed the "Debasement Trade"... And it could affect you and your money in a MAJOR way. Dr. David Eifrig's latest warning deserves your attention.
Trump Hits Sherrill, Boosts Ciattarelli In New Jersey
Donald Trump attacks Mikie Sherrill in NJ telerally, backs Jack Ciattarelli, sparking energy policy clashes and sharp campaign rebuttals statewide.
The New Gold Trade Dominating on Wall Street - Ad
Wall Street has been making headlines lately for piling into gold. According to Dr. David Eifrig, the gold bull run is just getting started. He says you should move your money to his No. 1 gold stock immediately (not a miner or ETF but it has 1,000% upside potential.)
16 Stocks To Buy If You Want To Escape The AI Hype
Bank of America is pointing investors toward 16 overlooked stocks with strong fundamentals and no direct ties to the AI boom—offering a safer path beyond the hype.
Meta, Alphabet, Chipotle, Microsoft And Starbucks: Why These 5 Stocks Are On Investors' Radars Today
Major stock indexes traded mixed on Wednesday, with the Dow Jones Industrial Average slipping nearly 0.2% to 47,632 and the S&P 500 holding steady at 6,890.59.
Buy This Stock Tomorrow? - Ad
A renowned former hedge fund manager - friends to some of the biggest investors in the world - just released a new list of his favorite AI stocks... and not a single Magnificent 7 name made the cut. Instead, an AI stock you've likely never heard of just flagged as "near-perfect" in his new investing scoring system.
Fintech company Fiserv slashes guidance, shuffles leadership after big earnings miss
WASHINGTON (AP) — Fiserv shares careened to their lowest level in more than five years Wednesday after the fintech payment company badly missed Wall Street's profit targets, lowered its forecast and announced a shake-up in leadership.
Obesity, diabetes treatments fuel Eli Lilly growth and spark bidding war
The market for obesity and diabetes treatments remains scorching hot, funneling billions in sales to Eli Lilly and fueling a bidding war over another drugmaker.
This Overlooked Memecoin Is Showing Early Breakout Signals - Ad
We've been tracking one small memecoin that checks all the boxes: strong on-chain signals, real traction, and an entry point that could offer serious upside. It's not on many radars yet-but that could change fast.
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and deserve attention.
Traders Love This Time Of Year For Broadcom — Here's Why It Rarely Fails
Broadcom stock has gained in 14 of the last 16 mid-November to mid-December periods, with an average return of 8.9%.
The K7 Is Changing the Economics of Security - Ad
$65-an-hour guards can't compete with a $15-an-hour AI machine that never sleeps. The K7 delivers nonstop protection and smarter analytics that improve with every patrol.
MacKenzie Scott gives $60 million to the Center for Disaster Philanthropy
MacKenzie Scott, one of the world's richest women and most influential philanthropists, has donated $60 million to the Center for Disaster Philanthropy, according to a Tuesday announcement from the nonprofit.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.